載入...
Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor
The efficacy of low molecular weight heparin (LMWH) with low dose unfractionated heparin (UFH) during percutaneous coronary intervention (PCI) with or without glycoprotein (Gp) IIb/IIIa inhibitor compared to UFH with or without Gp IIb/IIIa inhibitor has not been elucidated. Between October 2005 and...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Korean Academy of Medical Sciences
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2966997/ https://ncbi.nlm.nih.gov/pubmed/21060749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2010.25.11.1601 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|